Intraosseous Infusion Device Trends and Forecast
The future of the global intraosseous infusion device market looks promising with opportunities in the EMS, hospital, ambulatory surgical center, and cardiac care center markets. The global intraosseous infusion device market is expected to reach an estimated $7.1 billion by 2030 with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are increased demand for rapid fluid administration, growing focus on patient safety and reducing complications associated with IV access, as well as, greater knowledge of recently introduced therapeutic procedures and technologies among physicians and patients.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Intraosseous Infusion Device by Segment
The study includes a forecast for the global intraosseous infusion device by technology, product, route of administration, end use, and region.
Intraosseous Infusion Device Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
• Manual
• Automatic
• Impact Driven
• Power Drill
Intraosseous Infusion Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:
• B.I.G
• FAST1
• EZ-IO
• FASTR
• IO Needles
• Others
Intraosseous Infusion Device Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Sternum
• Distal & Proximal Tibia
• Distal Femur
• Calcaneus
• Head Of Humerus
Intraosseous Infusion Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• EMS
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Care Centers
• Others
Intraosseous Infusion Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Intraosseous Infusion Device Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intraosseous infusion device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intraosseous infusion device companies profiled in this report include-
• Pyng Medical
• Biopsybell
• Cook Medical
• PAVmed
• PerSys Medical
• Aero Healthcare
• Teleflex
• Becton Dickinson and Company
• SAM Medical
• Cardinal Health
Intraosseous Infusion Device Market Insights
Lucintel forecasts that automatic will remain the largest segment over the forecast period.
Within this market, EMS will remain the largest segment due to rising demand for IoT devices with various advances and leveraging new scientific advances.
North America will remain the largest region over the forecast period due to high frequency of cardiovascular diseases, excellent health reimbursement, and greater awareness in the region.
Features of the Global Intraosseous Infusion Device Market
Market Size Estimates: Intraosseous infusion device market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Intraosseous infusion device market size by technology, product, route of administration, end use, and region in terms of value ($B).
Regional Analysis: Intraosseous infusion device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technology, product, route of administration, end use, and regions for the intraosseous infusion device market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intraosseous infusion device market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the intraosseous infusion device market size?
Answer: The global intraosseous infusion device market is expected to reach an estimated $7.1 billion by 2030.
Q2. What is the growth forecast for intraosseous infusion device market?
Answer: The global intraosseous infusion device market is expected to grow with a CAGR of 6.8% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the intraosseous infusion device market?
Answer: The major drivers for this market are increased demand for rapid fluid administration, growing focus on patient safety and reducing complications associated with IV access, as well as, greater knowledge of recently introduced therapeutic procedures and technologies among physicians and patients.
Q4. What are the major segments for intraosseous infusion device market?
Answer: The future of the global intraosseous infusion device market looks promising with opportunities in the EMS, hospital, ambulatory surgical center, and cardiac care center markets.
Q5. Who are the key intraosseous infusion device market companies?
Answer: Some of the key intraosseous infusion device companies are as follows:
• Pyng Medical
• Biopsybell
• Cook Medical
• PAVmed
• PerSys Medical
• Aero Healthcare
• Teleflex
• Becton Dickinson and Company
• SAM Medical
• Cardinal Health
Q6. Which intraosseous infusion device market segment will be the largest in future?
Answer: Lucintel forecasts that automatic will remain the largest segment over the forecast period.
Q7. In intraosseous infusion device market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high frequency of cardiovascular diseases, excellent health reimbursement, and greater awareness in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the intraosseous infusion device market by technology (manual, automatic, impact driven, and power drill), product (B.I.G, FAST1, EZ-IO, FASTR, OI needles, and others), route of administration (sternum, distal & proximal tibia, distal femur, calcaneus, and head of humerus), end use (EMS, hospitals, ambulatory surgical centers, cardiac care centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Intraosseous Infusion Device Market, Intraosseous Infusion Device Market Size, Intraosseous Infusion Device Market Growth, Intraosseous Infusion Device Market Analysis, Intraosseous Infusion Device Market Report, Intraosseous Infusion Device Market Share, Intraosseous Infusion Device Market Trends, Intraosseous Infusion Device Market Forecast, Intraosseous Infusion Device Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.